Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -680 | -3,032 | -2,377 | -1,671 | -836 |
| Depreciation Amortization | 85 | 283 | 171 | 117 | 55 |
| Accounts receivable | -185 | -17 | 62 | 36 | -181 |
| Other Working Capital | -267 | -18 | 40 | 441 | 62 |
| Other Operating Activity | 388 | 672 | 520 | 283 | 378 |
| Operating Cash Flow | $-659 | $-2,112 | $-1,584 | $-794 | $-522 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -45 | -45 | -40 | -26 |
| Investing Cash Flow | $N/A | $-45 | $-45 | $-40 | $-26 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,187 | N/A | 1,187 | N/A |
| Debt Repayment | N/A | N/A | 1,187 | N/A | N/A |
| Common Stock Issued | 1,187 | 1 | 1 | 1 | 1 |
| Financing Cash Flow | $1,187 | $1,188 | $1,188 | $1,188 | $1 |
| Exchange Rate Effect | N/A | -4 | N/A | N/A | N/A |
| Beginning Cash Position | 275 | 1,248 | 1,248 | 1,248 | 1,248 |
| End Cash Position | 803 | 275 | 807 | 1,602 | 701 |
| Net Cash Flow | $528 | $-973 | $-441 | $354 | $-547 |
| Free Cash Flow | |||||
| Operating Cash Flow | -659 | -2,112 | -1,584 | -794 | -522 |
| Capital Expenditure | N/A | -45 | -45 | -40 | -26 |
| Free Cash Flow | -659 | -2,157 | -1,629 | -834 | -548 |